Downloadable Slides


Share

Program Content

Activities

  • CDK4_6 Inhibitors in HR+, HER2-Negative Breast Cancer
    Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • Inhibiteurs de CDK4/6 cancer du sein HR+/HER2-
    Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • Inibidores de CDK4/6 em câncer de mama HR+/HER2-
    Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2024

    Expires: August 18, 2025

  • Los inhibidores de CDK4/6 en el cáncer de mama RH+/HER2-
    Conversaciones sobre el cáncer de mama RH positivo/HER2 negativo en el panorama terapéutico en expansión de los inhibidores de CDK4/6
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 21, 2024

    Expires: August 20, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation